Management of ST Segment Depression
Initial Assessment and Diagnosis
- ST segment depression on ECG is a significant finding that may indicate myocardial ischemia and is often associated with non-ST elevation acute coronary syndrome (NSTE-ACS), according to the European Society of Cardiology 1, 2
- Immediate 12-lead ECG should be obtained and interpreted as soon as possible at the first medical contact to facilitate early diagnosis and triage, as recommended by the European Heart Journal 3, 4
- ECG monitoring should be initiated immediately in all patients with suspected ACS to detect life-threatening arrhythmias, based on guidelines from the European Heart Journal 3, 5
- ST segment depression ≥0.5 mm in leads V1-V3 may represent posterior myocardial infarction, especially when the terminal T-wave is positive (ST-segment elevation equivalent), according to the European Heart Journal 3, 4
Risk Stratification
- Patients with ST segment depression should be classified as high-risk if they present with recurrent ischemia (either recurrent chest pain or dynamic ST-segment changes), as stated by the European Society of Cardiology 1, 2
- Elevated cardiac troponin levels are also a high-risk indicator, according to the European Society of Cardiology 1, 2, 6
- Hemodynamic instability is another factor that classifies patients as high-risk, based on guidelines from the European Society of Cardiology 1, 2
- Major arrhythmias (repetitive ventricular tachycardia, ventricular fibrillation) are a high-risk indicator, as stated by the European Society of Cardiology 1, 2
- Diabetes mellitus is also a risk factor, according to the European Society of Cardiology 2
Immediate Management
- Aspirin 75-150 mg daily should be administered immediately, as recommended by the European Society of Cardiology 1, 2
- Clopidogrel should be added to aspirin in patients with NSTE-ACS, according to the European Society of Cardiology 1, 2
- Low molecular weight heparin (LMWH) or unfractionated heparin should be administered, as recommended by the European Society of Cardiology 1, 2
- Beta-blockers should be administered in the absence of contraindications, according to the American Heart Association 1, 2
- Oral or intravenous nitrates should be given for persistent or recurrent chest pain, as recommended by the European Society of Cardiology 1, 2
Invasive Management Strategy
- High-risk patients should undergo coronary angiography as soon as possible, ideally within 48 hours, as stated by the European Society of Cardiology 1, 2
- Patients with severe ongoing ischemia, major arrhythmias, or hemodynamic instability should undergo immediate angiography (within the first hour), according to the European Society of Cardiology 2
Monitoring and Follow-up
- Continuous ECG monitoring for arrhythmias should be continued for at least 24 hours or until an alternative diagnosis has been made, as recommended by the European Heart Journal 9
- Serial troponin measurements should be obtained (typically at 6-12 hour intervals) to detect myocardial damage, according to the European Society of Cardiology 1, 2
- Echocardiography should be performed to assess left ventricular function and to rule out other cardiovascular causes of chest pain, as recommended by the European Society of Cardiology 1, 2
Long-term Management
- Dual antiplatelet therapy (DAPT) should be continued for up to 1 year in patients who undergo PCI, as recommended by the European Society of Cardiology 8
- Secondary prevention measures including statins, ACE inhibitors (especially in patients with reduced left ventricular function), and lifestyle modifications should be implemented, according to the American Heart Association 7
- Cardiac rehabilitation programs are recommended, particularly for patients with multiple modifiable risk factors, as stated by the American Heart Association 7